BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20637638)

  • 1. The marine sponge metabolite mycothiazole: a novel prototype mitochondrial complex I inhibitor.
    Morgan JB; Mahdi F; Liu Y; Coothankandaswamy V; Jekabsons MB; Johnson TA; Sashidhara KV; Crews P; Nagle DG; Zhou YD
    Bioorg Med Chem; 2010 Aug; 18(16):5988-94. PubMed ID: 20637638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial genome-knockout cells demonstrate a dual mechanism of action for the electron transport complex I inhibitor mycothiazole.
    Meyer KJ; Singh AJ; Cameron A; Tan AS; Leahy DC; O'Sullivan D; Joshi P; La Flamme AC; Northcote PT; Berridge MV; Miller JH
    Mar Drugs; 2012 Apr; 10(4):900-917. PubMed ID: 22690150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kalkitoxin inhibits angiogenesis, disrupts cellular hypoxic signaling, and blocks mitochondrial electron transport in tumor cells.
    Morgan JB; Liu Y; Coothankandaswamy V; Mahdi F; Jekabsons MB; Gerwick WH; Valeriote FA; Zhou YD; Nagle DG
    Mar Drugs; 2015 Mar; 13(3):1552-68. PubMed ID: 25803180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic 2,5-disubstituted pyrroles from the marine sponge Mycale sp. inhibit mitochondrial respiration and HIF-1 activation.
    Mao SC; Liu Y; Morgan JB; Jekabsons MB; Zhou YD; Nagle DG
    J Nat Prod; 2009 Nov; 72(11):1927-36. PubMed ID: 19845338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways.
    Liu Y; Veena CK; Morgan JB; Mohammed KA; Jekabsons MB; Nagle DG; Zhou YD
    J Biol Chem; 2009 Feb; 284(9):5859-68. PubMed ID: 19091749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-targeted antitumor agents. 19. Furospongolide from a marine Lendenfeldia sp. sponge inhibits hypoxia-inducible factor-1 activation in breast tumor cells.
    Liu Y; Liu R; Mao SC; Morgan JB; Jekabsons MB; Zhou YD; Nagle DG
    J Nat Prod; 2008 Nov; 71(11):1854-60. PubMed ID: 18989978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reassignment of (-)-mycothiazole and the isolation of a related diol.
    Sonnenschein RN; Johnson TA; Tenney K; Valeriote FA; Crews P
    J Nat Prod; 2006 Jan; 69(1):145-7. PubMed ID: 16441088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures and mechanisms of antitumor agents: xestoquinones uncouple cellular respiration and disrupt HIF signaling in human breast tumor cells.
    Du L; Mahdi F; Datta S; Jekabsons MB; Zhou YD; Nagle DG
    J Nat Prod; 2012 Sep; 75(9):1553-9. PubMed ID: 22938093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of new piperazine-type inhibitors for mitochondrial NADH-ubiquinone oxidoreductase (complex I).
    Ichimaru N; Murai M; Kakutani N; Kako J; Ishihara A; Nakagawa Y; Nishioka T; Yagi T; Miyoshi H
    Biochemistry; 2008 Oct; 47(40):10816-26. PubMed ID: 18781777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular-targeted antitumor agents. 15. Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells.
    Liu R; Liu Y; Zhou YD; Nagle DG
    J Nat Prod; 2007 Nov; 70(11):1741-5. PubMed ID: 17958397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
    Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
    Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia.
    Agani FH; Pichiule P; Chavez JC; LaManna JC
    J Biol Chem; 2000 Nov; 275(46):35863-7. PubMed ID: 10961998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-selective antitumor agents: norsesterterpene peroxides from the marine sponge Diacarnus levii preferentially suppress the growth of tumor cells under hypoxic conditions.
    Dai J; Liu Y; Zhou YD; Nagle DG
    J Nat Prod; 2007 Jan; 70(1):130-3. PubMed ID: 17253866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
    Chen MC; Hsu WL; Hwang PA; Chou TC
    Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration.
    Liu Y; Morgan JB; Coothankandaswamy V; Liu R; Jekabsons MB; Mahdi F; Nagle DG; Zhou YD
    J Nat Prod; 2009 Dec; 72(12):2104-9. PubMed ID: 19921787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic metabolites from an Indonesian sponge Lendenfeldia sp.
    Dai J; Liu Y; Zhou YD; Nagle DG
    J Nat Prod; 2007 Nov; 70(11):1824-6. PubMed ID: 17958396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.
    Thirusangu P; Vigneshwaran V; Prashanth T; Vijay Avin BR; Malojirao VH; Rakesh H; Khanum SA; Mahmood R; Prabhakar BT
    Angiogenesis; 2017 Feb; 20(1):55-71. PubMed ID: 27743086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial respiration inhibitors suppress protein translation and hypoxic signaling via the hyperphosphorylation and inactivation of translation initiation factor eIF2α and elongation factor eEF2.
    Li J; Mahdi F; Du L; Datta S; Nagle DG; Zhou YD
    J Nat Prod; 2011 Sep; 74(9):1894-901. PubMed ID: 21875114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.